Low locoregional recurrence rates in patients treated after 2000 with doxorubicin based chemotherapy, modified radical mastectomy, and post-mastectomy radiation

Radiotherapy and Oncology

Volumn 95, Issue 3, 2010, Pages 312-316

  Greenbaum, Michael P ^a   Strom, Eric A ^b   Allen, Pamela K ^b   Perkins, George H ^b   Oh, Julia L ^b   Tereffe, Welela ^b   Yu, Tse Kuan ^b   Buchholz, Thomas A ^b   Woodward, Wendy A ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

3D treatment planning; Locoregional control; Locoregional recurrence; PMRT; Post mastectomy radiation therapy

Indexed keywords

DOXORUBICIN;

ADJUVANT THERAPY; ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; OUTCOME ASSESSMENT; POST MASTECTOMY RADIATION THERAPY; PRIORITY JOURNAL; TREATMENT PLANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 77952583299     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.02.013     Document Type: Article

References (23)

1. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
2. Ragaz J., Olivotto I.A., Spinelli J.J., et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97 (2005) 116-126
3. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
4. Buzdar A.U., Blumenschein G.R., Smith T.L., et al. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial. Cancer 53 (1984) 384-389
5. Buzdar A.U., Blumenschein G.R., Montague E.D., et al. Combined modality approach in breast cancer with isolated or multiple metastases. Am J Clin Oncol 7 (1984) 45-50
6. Buzdar A.U., Hortobagyi G.N., Marcus C.E., Smith T.L., Martin R., and Gehan E.A. Results of adjuvant chemotherapy trials in breast cancer at M. D. Anderson Hospital and Tumor Institute. NCI Monogr (1986) 81-85
7. Buzdar A.U., Hortobagyi G.N., Smith T.L., et al. Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs. Cancer 62 (1988) 2098-2104
8. Buzdar A.U., Kau S.W., Smith T.L., and Hortobagyi G.N. Ten-year results of FAC adjuvant chemotherapy trial in breast cancer. Am J Clin Oncol 12 (1989) 123-128
9. Buzdar A.U., Hortobagyi G.N., Kau S.W., et al. Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer. J Clin Oncol 10 (1992) 1540-1546
10. Theriault R., Buzdar A.U., Hortobagyi G.N., et al. Irradiation (XRT) following mastectomy in patients treated with FAC adjuvant therapy-MD Anderson Cancer Center experience. Proc Am Soc Clin Oncol 10 (1998) (abstr 381)
11. Woodward W.A., Strom E.A., Tucker S.L., et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys 57 (2003) 336-344
12. Huang E.H., Tucker S.L., Strom E.A., et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22 (2004) 4691-4699
13. The World Health Organization Histological Typing of Breast Tumors-Second Edition. Am J Clin Pathol 1982;78:806-16.
14. Black M.M., and Speer F.D. Nuclear structure in cancer tissues. Surg Gynecol Obstet 105 (1957) 97-102
15. Harris E., and Albert A. Estimating survival probabilities. In: Harris E., and Albert A. (Eds). Survivorship analysis for clinical studies (1991), Marcel Dekker, Inc., New York 3-35
16. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 (2005) 2087-2106
17. Bauduceau O., Bollet M.A., Pons P., et al. The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?. J Buon 13 (2008) 245-251
18. Thomsen M.S., Berg M., Nielsen H.M., et al. Post-mastectomy radiotherapy in Denmark: from 2D to 3D treatment planning guidelines of The Danish Breast Cancer Cooperative Group. Acta Oncol 47 (2008) 654-661
19. Perkins G.H., McNeese M.D., Antolak J.A., Buchholz T.A., Strom E.A., and Hogstrom K.R. A custom three-dimensional electron bolus technique for optimization of postmastectomy irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 1142-1151
20. Krueger E.A., Fraass B.A., McShan D.L., Marsh R., and Pierce L.J. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1023-1037
21. Sartor C.I., Peterson B.L., Woolf S., et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: cancer and leukemia group B 9344. J Clin Oncol 23 (2005) 30-40
22. Feinstein A.R., Sosin D.M., and Wells C.K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312 (1985) 1604-1608
23. Woodward W.A., Strom E.A., Tucker S.L., et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21 (2003) 3244-3248